000 01264 a2200325 4500
005 20250515033501.0
264 0 _c20070109
008 200701s 0 0 eng d
022 _a1618-7598
024 7 _a10.1007/s10198-006-0357-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDalen, Dag Morten
245 0 0 _aPrice regulation and generic competition in the pharmaceutical market.
_h[electronic resource]
260 _bThe European journal of health economics : HEPAC : health economics in prevention and care
_cSep 2006
300 _a208-14 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCommerce
_xeconomics
650 0 4 _aCost Control
650 0 4 _aDrug Industry
_xeconomics
650 0 4 _aDrugs, Generic
_xeconomics
650 0 4 _aEconomic Competition
_xeconomics
650 0 4 _aHumans
650 0 4 _aLegislation, Drug
_xeconomics
650 0 4 _aModels, Econometric
650 0 4 _aNorway
700 1 _aStrøm, Steinar
700 1 _aHaabeth, Tonje
773 0 _tThe European journal of health economics : HEPAC : health economics in prevention and care
_gvol. 7
_gno. 3
_gp. 208-14
856 4 0 _uhttps://doi.org/10.1007/s10198-006-0357-y
_zAvailable from publisher's website
999 _c16432051
_d16432051